Literature DB >> 8633178

MR cholangiopancreatography after unsuccessful or incomplete ERCP.

J A Soto1, E K Yucel, M A Barish, R Chuttani, J T Ferrucci.   

Abstract

PURPOSE: To assess the value of magnetic resonance (MR) cholangiopancreatography in patients in whom endoscopic retrograde cholangiopancreatography (ERCP) was unsuccessful or did not completely delineate ductal abnormalities.
MATERIALS AND METHODS: MR cholangiopancreatography was performed in 37 consecutive patients because ERCP was unsuccessful (n = 20), postsurgical biliary-enteric anatomy was present (n = 10), or evidence of complete pancreatic duct obstruction was found ar ERCP (n = 7).
RESULTS: MR cholangiopancreatography was successful in all patients. Eleven patients had normal MR findings and required no further intervention. Eight patients has abnormalities that were detected with MR but were followed up clinically. Eleven patients subsequently underwent laparotomy, three underwent therapeutic percutaneous transhepatic cholangiography (PTC), two underwent diagnostic (PTC), and one underwent ultrasound-guided biopsy.
CONCLUSIONS: MR cholangiopancreatography plays an important role in the care of patients in whom ERCP is unsuccessful or incomplete and when technical difficulties can be anticipated.

Entities:  

Mesh:

Year:  1996        PMID: 8633178     DOI: 10.1148/radiology.199.1.8633178

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Cost-effective management of common bile duct stones: a decision analysis of the use of endoscopic retrograde cholangiopancreatography (ERCP), intraoperative cholangiography, and laparoscopic bile duct exploration.

Authors:  D R Urbach; Y S Khajanchee; B A Jobe; B A Standage; P D Hansen; L L Swanstrom
Journal:  Surg Endosc       Date:  2001-01       Impact factor: 4.584

Review 2.  Noninvasive imaging of the biliary ducts.

Authors:  J T Ferrucci
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

3.  Imaging diagnosis of pancreato-biliary diseases: a control study.

Authors:  Liang Zhong; Qiu-Ying Yao; Lei Li; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP.

Authors:  László Czakó; Tamás Takács; Zita Morvay; László Csernay; János Lonovics
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

5.  Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography.

Authors:  Thomas J Vogl; Wolfram O Schwarz; Matthias Heller; Christopher Herzog; Stephan Zangos; Rainer E Hintze; Peter Neuhaus; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

6.  Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques.

Authors:  Liang Zhong; Lei Li; Qiu-Ying Yao
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

7.  The Value of Magnetic Resonance Cholangio-Pancreatography (MRCP) in the Detection of Choledocholithiasis.

Authors:  Ankur Mandelia; Arun Kumar Gupta; Devendra Kumar Verma; Sanjeev Sharma
Journal:  J Clin Diagn Res       Date:  2013-09-10

8.  Use of magnetic resonance cholangiography in the diagnosis of choledocholithiasis: prospective comparison with a reference imaging method.

Authors:  S H Zidi; F Prat; O Le Guen; Y Rondeau; L Rocher; J Fritsch; A D Choury; G Pelletier
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 9.  Detecting blunt pancreatic injuries.

Authors:  Robert L Cirillo; Leonidas G Koniaris
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

10.  Clinical models are inaccurate in predicting bile duct stones in situ for patients with gallbladder.

Authors:  B Topal; S Fieuws; K Tomczyk; R Aerts; W Van Steenbergen; C Verslype; F Penninckx
Journal:  Surg Endosc       Date:  2008-04-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.